Article
Methodology for Discovery of Alzheimer's Disease Blood-Based Biomarkers
14 Apr 2009
Abstract excerpt
Alzheimer's disease (AD) is a degenerative brain disorder. The disease also affects peripheral tissue such as peripheral blood mononuclear cells (PBMCs). Delineating biochemical alterations in AD blood constituents may possibly allow the identification of accessible footprints that reflect degenerative processes within the central nervous system. Here, we describe an integrated methodology for the generation of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
